216 related articles for article (PubMed ID: 34361032)
1. Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor
Yang Y; Xu X; Wu H; Yang J; Chen J; Morisseau C; Hammock BD; Bettaieb A; Zhao L
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361032
[TBL] [Abstract][Full Text] [Related]
2. Soluble Epoxide Hydrolase Inhibition by
Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
Zhang CH; Zheng L; Gui L; Lin JY; Zhu YM; Deng WS; Luo M
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):118-125. PubMed ID: 29031875
[TBL] [Abstract][Full Text] [Related]
5. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
Araki M; Nakagawa Y; Oishi A; Han SI; Wang Y; Kumagai K; Ohno H; Mizunoe Y; Iwasaki H; Sekiya M; Matsuzaka T; Shimano H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041488
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase inhibitor, t-TUCB, protects against myocardial ischaemic injury in rats.
Shrestha A; Krishnamurthy PT; Thomas P; Hammock BD; Hwang SH
J Pharm Pharmacol; 2014 Sep; 66(9):1251-8. PubMed ID: 24697323
[TBL] [Abstract][Full Text] [Related]
7. Mice fed fish oil diet and upregulation of brown adipose tissue thermogenic markers.
Bargut TC; Silva-e-Silva AC; Souza-Mello V; Mandarim-de-Lacerda CA; Aguila MB
Eur J Nutr; 2016 Feb; 55(1):159-69. PubMed ID: 25612928
[TBL] [Abstract][Full Text] [Related]
8. Emodin Improves Glucose and Lipid Metabolism Disorders in Obese Mice
Cheng L; Zhang S; Shang F; Ning Y; Huang Z; He R; Sun J; Dong S
Front Endocrinol (Lausanne); 2021; 12():618037. PubMed ID: 34040579
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
10. Anti-nociceptive efficacy of the soluble epoxide hydrolase inhibitor t-TUCB in horses with mechanically induced lameness.
Carlson A; Johnson PJ; Lei Z; Keegan KG
Res Vet Sci; 2022 Dec; 152():504-509. PubMed ID: 36174370
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.
Wagner K; Gilda J; Yang J; Wan D; Morisseau C; Gomes AV; Hammock BD
Behav Brain Res; 2017 May; 326():69-76. PubMed ID: 28259677
[TBL] [Abstract][Full Text] [Related]
14. Effect of quercetin on nonshivering thermogenesis of brown adipose tissue in high-fat diet-induced obese mice.
Pei Y; Otieno D; Gu I; Lee SO; Parks JS; Schimmel K; Kang HW
J Nutr Biochem; 2021 Feb; 88():108532. PubMed ID: 33130188
[TBL] [Abstract][Full Text] [Related]
15. Anti-Obesity Effects of
Lee HG; Lu YA; Li X; Hyun JM; Kim HS; Lee JJ; Kim TH; Kim HM; Kang MC; Jeon AY
Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991562
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
Wagner K; Yang J; Inceoglu B; Hammock BD
J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
[TBL] [Abstract][Full Text] [Related]
19. Loss of Adipose Fatty Acid Oxidation Does Not Potentiate Obesity at Thermoneutrality.
Lee J; Choi J; Aja S; Scafidi S; Wolfgang MJ
Cell Rep; 2016 Feb; 14(6):1308-1316. PubMed ID: 26854223
[TBL] [Abstract][Full Text] [Related]
20. Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.
Wang L; Yang J; Guo L; Uyeminami D; Dong H; Hammock BD; Pinkerton KE
Am J Respir Cell Mol Biol; 2012 May; 46(5):614-22. PubMed ID: 22180869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]